{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:57:24Z","timestamp":1761901044270,"version":"build-2065373602"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2024YFE0214800"],"award-info":[{"award-number":["2024YFE0214800"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82361168672"],"award-info":[{"award-number":["82361168672"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Development Fund of Macau SAR","award":["FDCT 0111\/2023\/AFJ"],"award-info":[{"award-number":["FDCT 0111\/2023\/AFJ"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Coinfections of influenza A virus (IAV) and herpes simplex virus type 1 (HSV-1) have been increasingly reported in patients with severe pneumonia, yet their pathogenesis remains poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We established murine models to investigate the effects of coinfection with HSV-1 (strain KOS) and IAV (A\/Aichi\/2\/1968 (H3N2)) under different orders of infection. Mice were assigned to one of five groups: (1) HSV-1 monoinfection, (2) H3N2 monoinfection, (3) simultaneous coinfection (H3N2\u2009+\u2009HSV-1), (4) sequential coinfection with H3N2 administered three days prior to HSV-1 (H3N2-HSV-1), and (5) sequential coinfection with HSV-1 administered three days prior to H3N2 (HSV-1-H3N2). We then compared disease severity, viral replication, lung injury, cytokine profiles along with innate and adaptive immune responses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, all coinfection groups developed more severe disease than HSV-1 monoinfection. However, when compared to H3N2 monoinfection, the order of coinfection resulted in distinct differences in disease severity and immune response patterns. Specifically, simultaneous H3N2\u2009+\u2009HSV-1 and sequential H3N2-HSV-1 coinfections led to increased mortality, higher H3N2 viral loads, and more pronounced pulmonary inflammation. These groups exhibited elevated cytokine levels and dysregulated immune responses, with the H3N2\u2009+\u2009HSV-1 group displaying reduced proportions of natural killer cells (NK), plasmacytoid dendritic cells (pDCs) and interferon-producing killer dendritic cells (IKDCs) in bronchoalveolar lavage fluid (BALF), while the H3N2-HSV-1 group showed a robust expansion of these innate immune cells. Additionally, these two coinfection strategies were associated with increased H3N2-specific IFN-\u03b3\u207aCD8\u207a T cells, reflecting an exacerbated adaptive response. In contrast, sequential HSV-1-H3N2 coinfection resulted in milder disease manifestations, characterized by lower mortality, decreased clinical severity, reduced cytokine levels, and diminished proportions of NK cells, pDCs, IKDCs, and CD8\u207a T cells in BALF. Moreover, H3N2-specific IFN-\u03b3\u207aCD8\u207a T cells were reduced in both lung and spleen tissues, indicating a more controlled immune activation during HSV-1-H3N2 coinfection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study demonstrates that the infection order of H3N2 and HSV-1 coinfection critically shapes disease outcomes. Specifically, sequential H3N2 infection preceding HSV-1 or simultaneous coinfection with H3N2 and HSV-1 exacerbated immunopathology. Conversely, prior HSV-1 exposure attenuated H3N2-driven inflammation via reduced cytokine levels and immune cell recruitment. This study provides novel insights into immune dysregulation in coinfection models, with potential translational implications for managing influenza and herpesvirus coinfections.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12985-025-02968-4","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:36:09Z","timestamp":1761899769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The order of infection shapes disease outcomes in influenza and herpes simplex virus coinfection by modulating immune responses"],"prefix":"10.1186","volume":"22","author":[{"given":"Yuanjun","family":"Lyu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kailin","family":"Mai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunguang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunceng","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zifeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"issue":"4","key":"2968_CR1","doi-asserted-by":"publisher","first-page":"e00111","DOI":"10.1128\/CMR.00111-17","volume":"31","author":"N Kumar","year":"2018","unstructured":"Kumar N, Sharma S, Barua S, Tripathi BN, Rouse BT. Virological and immunological outcomes of coinfections. Clin Microbiol Rev. 2018;31(4):e00111\u201317. https:\/\/doi.org\/10.1128\/CMR.00111-17.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"2968_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/jmv.25006","volume":"90","author":"E Antalis","year":"2018","unstructured":"Antalis E, Oikonomopoulou Z, Kottaridi C, Kossyvakis A, Spathis A, Magkana M, et al. Mixed viral infections of the respiratory tract; an epidemiological study during consecutive winter seasons. J Med Virol. 2018;90(4):663\u201370.","journal-title":"J Med Virol"},{"issue":"4","key":"2968_CR3","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3390\/pathogens13040316","volume":"13","author":"PI Babawale","year":"2024","unstructured":"Babawale PI, Guerrero-Plata A. Respiratory viral coinfections: insights into epidemiology, immune response, pathology, and clinical outcomes. Pathogens. 2024;13(4):316. https:\/\/doi.org\/10.3390\/pathogens13040316.","journal-title":"Pathogens"},{"issue":"10353","key":"2968_CR4","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0140-6736(22)00982-5","volume":"400","author":"TM Uyeki","year":"2022","unstructured":"Uyeki TM, Hui DS, Zambon M, Wentworth DE, Monto AS. Influenza. Lancet. 2022;400(10353):693\u2013706.","journal-title":"Lancet"},{"issue":"4","key":"2968_CR5","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jinf.2011.04.004","volume":"63","author":"FP Esper","year":"2011","unstructured":"Esper FP, Spahlinger T, Zhou L. Rate and influence of respiratory virus co-infection on pandemic (H1N1) influenza disease. J Infect. 2011;63(4):260\u20136.","journal-title":"J Infect"},{"issue":"1","key":"2968_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s44307-025-00057-9","volume":"3","author":"K-L Mai","year":"2025","unstructured":"Mai K-L, Pan W-Q, Lin Z-S, Wang Y, Yang Z-F. Pathogenesis of influenza and SARS-CoV-2 co-infection at the extremes of age: decipher the ominous tales of immune vulnerability. Adv Biotechnol. 2025;3(1):5.","journal-title":"Adv Biotechnol"},{"key":"2968_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104685","volume":"133","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhao J, Zou X, Fan Y, Xiong Z, Li B, et al. Severity of influenza virus and respiratory syncytial virus coinfections in hospitalized adult patients. J Clin Virol. 2020;133:104685.","journal-title":"J Clin Virol"},{"issue":"11","key":"2968_CR8","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1038\/s41564-022-01242-5","volume":"7","author":"J Haney","year":"2022","unstructured":"Haney J, Vijayakrishnan S, Streetley J, Dee K, Goldfarb DM, Clarke M, et al. Coinfection by influenza A virus and respiratory syncytial virus produces hybrid virus particles. Nat Microbiol. 2022;7(11):1879\u201390.","journal-title":"Nat Microbiol"},{"issue":"9","key":"2968_CR9","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1164\/rccm.200609-1322OC","volume":"175","author":"C-E Luyt","year":"2007","unstructured":"Luyt C-E, Combes A, Deback C, Aubriot-Lorton M-H, Nieszkowska A, Trouillet J-L, et al. Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation. Am J Respir Crit Care Med. 2007;175(9):935\u201342.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2968_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28337","volume":"95","author":"L Huang","year":"2023","unstructured":"Huang L, Zhang X, Pang L, Sheng P, Wang Y, Yang F, et al. Viral reactivation in the lungs of patients with severe pneumonia is associated with increased mortality, a multicenter, retrospective study. J Med Virol. 2023;95(1):e28337.","journal-title":"J Med Virol"},{"issue":"1","key":"2968_CR11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jcv.2003.09.003","volume":"30","author":"J-W van den Brink","year":"2004","unstructured":"van den Brink J-W, Simoons-Smit AM, Beishuizen A, Girbes ARJ, van Strack RJM, Groeneveld ABJ. Respiratory herpes simplex virus type 1 infection\/colonisation in the critically ill: marker or mediator? J Clin Virol. 2004;30(1):68\u201372.","journal-title":"J Clin Virol"},{"issue":"5","key":"2968_CR12","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1007\/s40121-022-00674-0","volume":"11","author":"DR Giacobbe","year":"2022","unstructured":"Giacobbe DR, Di Bella S, Lovecchio A, Ball L, De Maria A, Vena A, et al. Herpes simplex virus 1 (HSV-1) reactivation in critically ill COVID-19 patients: a brief narrative review. Infect Dis Ther. 2022;11(5):1779\u201391.","journal-title":"Infect Dis Ther"},{"issue":"1","key":"2968_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13613-022-01062-0","volume":"12","author":"C-E Luyt","year":"2022","unstructured":"Luyt C-E, Burrel S, Mokrani D, Pineton de Chambrun M, Luyt D, Chommeloux J, et al. Herpesviridae lung reactivation and infection in patients with severe COVID-19 or influenza virus pneumonia: a comparative study. Ann Intensive Care. 2022;12(1):87.","journal-title":"Ann Intensive Care"},{"issue":"2","key":"2968_CR14","doi-asserted-by":"publisher","first-page":"e0117846","DOI":"10.1371\/journal.pone.0117846","volume":"10","author":"ZF Yang","year":"2015","unstructured":"Yang ZF, Mok CKP, Liu XQ, Li XB, He JF, Guan WD, et al. Clinical, virological and immunological features from patients infected with re-emergent avian-origin human H7N9 influenza disease of varying severity in Guangdong Province. PLoS ONE. 2015;10(2):e0117846.","journal-title":"PLoS ONE"},{"issue":"3","key":"2968_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.arbr.2018.01.003","volume":"54","author":"T Pereiro","year":"2018","unstructured":"Pereiro T, Lourido T, Ricoy J, Vald\u00e9s L. Influenza virus, herpes simplex virus and Methicillin-Resistant Staphylococcus aureus coinfection in an immunocompetent patient. Arch Bronconeumol (Engl Ed). 2018;54(3):159\u201360.","journal-title":"Arch Bronconeumol (Engl Ed)"},{"issue":"2","key":"2968_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1001\/jamainternmed.2019.5713","volume":"180","author":"C-E Luyt","year":"2020","unstructured":"Luyt C-E, Forel J-M, Hajage D, Jaber S, Cayot-Constantin S, Rimmel\u00e9 T, et al. Acyclovir for mechanically ventilated patients with herpes simplex virus oropharyngeal reactivation: a randomized clinical trial. JAMA Intern Med. 2020;180(2):263\u201372.","journal-title":"JAMA Intern Med"},{"issue":"4","key":"2968_CR17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.virs.2023.06.002","volume":"38","author":"D Luo","year":"2023","unstructured":"Luo D, Ye Q, Li R-T, Zhou H-Y, Guo J-J, Zhao S-Q, et al. PA-E18G substitution in influenza A virus confers resistance to ZX-7101, a cap-dependent endonuclease inhibitor. Virol Sin. 2023;38(4):559\u201367.","journal-title":"Virol Sin"},{"key":"2968_CR18","doi-asserted-by":"publisher","first-page":"1441476","DOI":"10.3389\/fmicb.2024.1441476","volume":"15","author":"Z Liu","year":"2024","unstructured":"Liu Z, Qi C-J, Shi Y, Li T, Fang Y, Zhang Q. Active herpesviruses are associated with intensive care unit (ICU) admission in patients pulmonary infection and alter the respiratory microbiome. Front Microbiol. 2024;15:1441476.","journal-title":"Front Microbiol"},{"issue":"2","key":"2968_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.medcli.2022.04.013","volume":"160","author":"MJ P\u00e9rez-Pedrero S\u00e1nchez-Belmonte","year":"2023","unstructured":"P\u00e9rez-Pedrero S\u00e1nchez-Belmonte MJ, S\u00e1nchez-Casado M, Moran Gallego FJ, Piza Pinilla R, Gomez Hernando C, Paredes Borrachero I. Herpes simplex virus type 1 (HSV-1) over-infection in patients with acute respiratory distress syndrome secondary to COVID-19 pneumonia: impact on mortality. Med Clin (Barc). 2023;160(2):66\u201370.","journal-title":"Med Clin (Barc)"},{"issue":"10","key":"2968_CR20","doi-asserted-by":"publisher","first-page":"e0140765","DOI":"10.1371\/journal.pone.0140765","volume":"10","author":"KJ Looker","year":"2015","unstructured":"Looker KJ, Magaret AS, May MT, Turner KME, Vickerman P, Gottlieb SL, et al. Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS ONE. 2015;10(10):e0140765.","journal-title":"PLoS ONE"},{"issue":"2","key":"2968_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.medcli.2022.04.013","volume":"160","author":"MJ P\u00e9rez-Pedrero S\u00e1nchez-Belmonte","year":"2022","unstructured":"P\u00e9rez-Pedrero S\u00e1nchez-Belmonte MJ, S\u00e1nchez-Casado M, Moran Gallego FJ, Piza Pinilla R, Gomez Hernando C, Paredes Borrachero I. Herpes simplex virus type 1 (HSV-1) over-infection in patients with acute respiratory distress syndrome secondary to COVID-19 pneumonia: impact on mortality. Med Clin (Barc). 2022;160(2):66\u201370.","journal-title":"Med Clin (Barc)"},{"key":"2968_CR22","doi-asserted-by":"crossref","unstructured":"Gonzalez AJ, Ijezie EC, Balemba OB, Miura TA. Attenuation of influenza A virus disease severity by viral coinfection in a mouse model. J Virol. 2018;92(23):e00881\u201318.","DOI":"10.1128\/JVI.00881-18"},{"issue":"4","key":"2968_CR23","doi-asserted-by":"publisher","first-page":"369","DOI":"10.4149\/av_2015_04_369","volume":"59","author":"L An\u010dicov\u00e1","year":"2015","unstructured":"An\u010dicov\u00e1 L, W\u00e1gnerov\u00e1 M, Janul\u00edkov\u00e1 J, Chalupkov\u00e1 A, Hrabovsk\u00e1 Z, Kostolansk\u00fd F, et al. Simultaneous infection with gammaherpes and influenza viruses enhances the host immune defense. Acta Virol. 2015;59(4):369\u201379.","journal-title":"Acta Virol"},{"issue":"12","key":"2968_CR24","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1177\/0885066620965941","volume":"36","author":"ME Jellinge","year":"2021","unstructured":"Jellinge ME, Hansen F, Coia JE, Song Z. Herpes simplex virus type 1 pneumonia-a review. J Intensive Care Med. 2021;36(12):1398\u2013402.","journal-title":"J Intensive Care Med"},{"issue":"13","key":"2968_CR25","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.15252\/embj.201593458","volume":"35","author":"MH Christensen","year":"2016","unstructured":"Christensen MH, Jensen SB, Miettinen JJ, Luecke S, Prabakaran T, Reinert LS, et al. HSV-1 ICP27 targets the TBK1-activated STING signalsome to inhibit virus-induced type I IFN expression. EMBO J. 2016;35(13):1385\u201399.","journal-title":"EMBO J"},{"issue":"10","key":"2968_CR26","doi-asserted-by":"publisher","first-page":"a038414","DOI":"10.1101\/cshperspect.a038414","volume":"11","author":"R Mu\u00f1oz-Moreno","year":"2021","unstructured":"Mu\u00f1oz-Moreno R, Mart\u00ednez-Romero C, Garc\u00eda-Sastre A. Induction and evasion of type-I interferon responses during influenza A virus infection. Cold Spring Harb Perspect Med. 2021;11(10):a038414. https:\/\/doi.org\/10.1101\/cshperspect.a038414.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"5","key":"2968_CR27","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1183\/09031936.00186214","volume":"45","author":"S Herold","year":"2015","unstructured":"Herold S, Becker C, Ridge KM, Budinger GRS. Influenza virus-induced lung injury: pathogenesis and implications for treatment. Eur Respir J. 2015;45(5):1463\u201378.","journal-title":"Eur Respir J"},{"issue":"9","key":"2968_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.997","volume":"11","author":"L Wei","year":"2023","unstructured":"Wei L, Wang X, Zhou H. Interaction among inflammasome, PANoptosise, and innate immune cells in infection of influenza virus: updated review. Immun Inflamm Dis. 2023;11(9):e997.","journal-title":"Immun Inflamm Dis"},{"issue":"8","key":"2968_CR29","doi-asserted-by":"publisher","first-page":"4496","DOI":"10.1128\/JVI.03413-12","volume":"87","author":"DL Turner","year":"2013","unstructured":"Turner DL, Bickham KL, Farber DL, Lefran\u00e7ois L. Splenic priming of virus-specific CD8 T cells following influenza virus infection. J Virol. 2013;87(8):4496\u2013506.","journal-title":"J Virol"},{"issue":"1","key":"2968_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01471-y","volume":"8","author":"L Sun","year":"2023","unstructured":"Sun L, Su Y, Jiao A, Wang X, Zhang B. T cells in health and disease. Signal Transduct Target Ther. 2023;8(1):235.","journal-title":"Signal Transduct Target Ther"},{"key":"2968_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00025","volume":"7","author":"S Duan","year":"2016","unstructured":"Duan S, Thomas PG. Balancing immune protection and immune pathology by CD8(+) T-cell responses to influenza infection. Front Immunol. 2016;7:25.","journal-title":"Front Immunol"},{"issue":"1","key":"2968_CR32","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1038\/s41467-024-46822-7","volume":"15","author":"IJ-H Foo","year":"2024","unstructured":"Foo IJ-H, Chua BY, Clemens EB, Chang SY, Jia X, McQuilten HA, et al. Prior infection with unrelated neurotropic virus exacerbates influenza disease and impairs lung T cell responses. Nat Commun. 2024;15(1):2619.","journal-title":"Nat Commun"},{"issue":"10","key":"2968_CR33","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s41577-024-01029-1","volume":"24","author":"THO Nguyen","year":"2024","unstructured":"Nguyen THO, Rowntree LC, Chua BY, Thwaites RS, Kedzierska K. Defining the balance between optimal immunity and immunopathology in influenza virus infection. Nat Rev Immunol. 2024;24(10):720\u201335.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2968_CR34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/infdis\/jis340","volume":"206","author":"MF Abdul-Careem","year":"2012","unstructured":"Abdul-Careem MF, Mian MF, Yue G, Gillgrass A, Chenoweth MJ, Barra NG, et al. Critical role of natural killer cells in lung immunopathology during influenza infection in mice. J Infect Dis. 2012;206(2):167\u201377.","journal-title":"J Infect Dis"},{"issue":"10 Suppl","key":"2968_CR35","doi-asserted-by":"publisher","first-page":"S92","DOI":"10.1097\/INF.0b013e318168b706","volume":"27","author":"TP Welliver","year":"2008","unstructured":"Welliver TP, Reed JL, Welliver RC. Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases. Pediatr Infect Dis J. 2008;27(10 Suppl):S92\u20136.","journal-title":"Pediatr Infect Dis J"},{"issue":"1 Suppl","key":"2968_CR36","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1378\/chest.106.1_Supplement.28S","volume":"106","author":"DV Tuxen","year":"1994","unstructured":"Tuxen DV. Prevention of lower respiratory herpes simplex virus infection with acyclovir in patients with adult respiratory distress syndrome. Chest. 1994;106(1 Suppl):S28\u201333.","journal-title":"Chest"},{"issue":"1","key":"2968_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13054-019-2701-5","volume":"24","author":"L Schuierer","year":"2020","unstructured":"Schuierer L, Gebhard M, Ruf H-G, Jaschinski U, Berghaus TM, Wittmann M, et al. Impact of acyclovir use on survival of patients with ventilator-associated pneumonia and high load herpes simplex virus replication. Crit Care. 2020;24(1):12.","journal-title":"Crit Care"},{"issue":"10","key":"2968_CR38","doi-asserted-by":"publisher","first-page":"e0276467","DOI":"10.1371\/journal.pone.0276467","volume":"17","author":"M-S Friedl","year":"2022","unstructured":"Friedl M-S, Djakovic L, Kluge M, Hennig T, Whisnant AW, Backes S, et al. HSV-1 and influenza infection induce linear and circular splicing of the long NEAT1 isoform. PLoS ONE. 2022;17(10):e0276467.","journal-title":"PLoS ONE"},{"issue":"16","key":"2968_CR39","doi-asserted-by":"publisher","first-page":"8411","DOI":"10.1128\/JVI.78.16.8411-8420.2004","volume":"78","author":"GT Melroe","year":"2004","unstructured":"Melroe GT, DeLuca NA, Knipe DM. Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production. J Virol. 2004;78(16):8411\u201320.","journal-title":"J Virol"},{"issue":"3","key":"2968_CR40","doi-asserted-by":"publisher","first-page":"e0068422","DOI":"10.1128\/spectrum.00684-22","volume":"10","author":"JP Cwick","year":"2022","unstructured":"Cwick JP, Owen JE, Kochetkova I, Hain KS, Horssen NV, Taylor MP. Superinfection exclusion of alphaherpesviruses interferes with virion trafficking. Microbiol Spectr. 2022;10(3):e0068422.","journal-title":"Microbiol Spectr"},{"issue":"8","key":"2968_CR41","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1128\/JVI.00089-16","volume":"90","author":"A Criddle","year":"2016","unstructured":"Criddle A, Thornburg T, Kochetkova I, DePartee M, Taylor MP. Gd-independent superinfection exclusion of alphaherpesviruses. J Virol. 2016;90(8):4049\u201358.","journal-title":"J Virol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02968-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02968-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02968-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:36:15Z","timestamp":1761899775000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02968-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2968"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02968-4","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"354"}}